Works by Hu, Zhihuang


Results: 38
    1
    2
    3

    Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.

    Published in:
    Supportive Care in Cancer, 2014, v. 22, n. 4, p. 979, doi. 10.1007/s00520-013-2043-9
    By:
    • Hu, Zhihuang;
    • Cheng, Ying;
    • Zhang, Hongyu;
    • Zhou, Caicun;
    • Han, Baohui;
    • Zhang, Yiping;
    • Huang, Cheng;
    • Chang, Jianhua;
    • Song, Xiangqun;
    • Liang, Jun;
    • Liang, Houjie;
    • Bai, Chunxue;
    • Yu, Shiying;
    • Chen, Jia;
    • Wang, Jie;
    • Pan, Hongming;
    • Chitkara, Denesh;
    • Hille, Darcy;
    • Zhang, Li
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC.

    Published in:
    OncoTargets & Therapy, 2013, v. 6, p. 1481, doi. 10.2147/OTT.S51887
    By:
    • Xuan Wu;
    • Wenhua Liang;
    • Xue Hou;
    • Zhong Lin;
    • Hongyun Zhao;
    • Yan Huang;
    • Wenfeng Fang;
    • Yuanyuan Zhao;
    • Jingxun Wu;
    • Yunpeng Yang;
    • Chong Xue;
    • Zhihuang Hu;
    • Jing Zhang;
    • Jianwei Zhang;
    • Yuxiang Ma;
    • Ting Zhou;
    • Tao Qin;
    • Li Zhang
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38